US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 1.3200
- +0.1600+13.79%
Close Apr 26 16:00 ET
21.14MMarket Cap-600P/E (TTM)
1.3400High1.1345Low51.20KVolume1.1500Open1.1600Pre Close64.70KTurnover0.38%Turnover RatioLossP/E (Static)16.01MShares10.470052wk High3.35P/B17.61MFloat Cap0.660052wk Low--Dividend TTM13.34MShs Float3600.0000Historical High--Div YieldTTM17.72%Amplitude0.6600Historical Low1.2630Avg Price1Lot Size
Alaunos Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -99.83%5K | -90.91%1K | 0 | 4K | 0 | 634.17%2.92M | 11K | 631.41%2.91M | 0 | 0 |
| Operating revenue | -99.83%5K | -90.91%1K | --0 | --4K | --0 | 634.17%2.92M | --11K | 631.41%2.91M | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -25.32%28.5M | -60.61%3.36M | -35.27%7.23M | -12.12%8.23M | 6.46%9.67M | -50.57%38.16M | -17.25%8.53M | -50.76%11.18M | -58.63%9.37M | -57.87%9.09M |
| Selling and administrative expenses | -7.02%12.22M | -16.99%2.43M | 9.02%3.58M | -11.20%3.05M | -9.61%3.17M | -52.32%13.14M | 39.62%2.93M | -59.84%3.28M | -62.19%3.43M | -57.40%3.51M |
| -General and administrative expense | -7.02%12.22M | -16.99%2.43M | 9.02%3.58M | ---- | ---- | -52.32%13.14M | --2.93M | --3.28M | ---- | ---- |
| Research and development costs | -34.93%16.28M | -83.36%933K | -53.68%3.66M | -12.65%5.19M | 16.56%6.5M | -49.60%25.02M | -31.76%5.61M | -45.64%7.89M | -56.25%5.94M | -58.16%5.58M |
| Operating profit | 19.14%-28.49M | 60.57%-3.36M | 12.46%-7.23M | 12.16%-8.23M | -6.46%-9.67M | 54.12%-35.24M | 17.36%-8.52M | 62.94%-8.26M | 58.63%-9.37M | 57.87%-9.09M |
| Net non-operating interest income expense | 39.09%-1.92M | 0 | 0 | -44.32%-1.07M | -24.89%-853K | -165.26%-3.15M | -19.19%-888K | -89.41%-841K | -740K | -683K |
| Non-operating interest expense | -39.09%1.92M | --0 | --0 | 44.32%1.07M | 24.89%853K | 165.26%3.15M | 19.19%888K | 89.41%841K | --740K | --683K |
| Other net income (expense) | -813.90%-4.73M | -1,893.20%-4.48M | -588.98%-1.24M | 200.00%522K | 2,485.00%477K | 187.92%662K | 133.88%250K | 3,528.57%254K | 661.29%174K | -322.22%-20K |
| Special income (charges) | -4,441.35%-5.77M | ---4.59M | ---1.43M | 84.21%245K | ---- | 117.97%133K | --0 | --0 | --133K | ---- |
| -Less：Restructuring and merger&acquisition | --1.27M | --850K | --419K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --4.8M | --3.79M | --1.01M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | -124.06%-298K | ---53K | ---- | -84.21%-245K | ---- | ---133K | --0 | ---- | ---133K | ---- |
| Other non- operating income (expenses) | 98.11%1.05M | -57.60%106K | -25.98%188K | 575.61%277K | 2,485.00%477K | 4,169.23%529K | 12,400.00%250K | 3,528.57%254K | 232.26%41K | -322.22%-20K |
| Income before tax | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M | 56.19%-9.93M | 54.59%-9.79M |
| Income tax | ||||||||||
| Net income | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M | 56.19%-9.93M | 54.59%-9.79M |
| Net income continuous Operations | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M | 56.19%-9.93M | 54.59%-9.79M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M | 56.19%-9.93M | 54.59%-9.79M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M | 56.19%-9.93M | 54.59%-9.79M |
| Basic earnings per share | 15.71%-33 | 18.37%-0.4898 | 0.00%-0.6 | 20.00%-0.6 | 20.00%-0.6 | -605.41%-39.15 | 20.00%-0.6 | 63.64%-0.6 | 54.55%-0.75 | 50.00%-0.75 |
| Diluted earnings per share | 15.71%-33 | 18.37%-0.4898 | 0.00%-0.6 | 20.00%-0.6 | 20.00%-0.6 | -605.41%-39.15 | 20.00%-0.6 | 63.64%-0.6 | 54.55%-0.75 | 50.00%-0.75 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
